Disease Diagnosis TRIZ Cases

Acid dissociation and size exclusion chromatography detect autoantibodies without drug interference to optimize therapy.

An in vitro method determines distinctive nutritional profiles by comparing direct and indirect biomarkers in diseased subjects against healthy controls.

Combines soluble tumor necrosis factor receptor 1, matrix metalloproteinase-9, and placental growth factor levels to identify at-risk pregnancies.

CE-MS detects cis-aconitate to overcome creatinine blind spots and enable early stage renal disease diagnosis.

Paper spray ionization mass spectrometry analyzes sebum samples to identify high molecular mass lipids for rapid diagnostic screening.

Analyzing PlGF-2 and PlGF-3 isoform ratios in maternal samples to assess preeclampsia risk.

Digital image analysis replaces manual selection to resolve spatial heterogeneity and inter-observer variability in cancer tissue quantification.

A multiplex aptamer-based assay detects non-small cell lung cancer biomarkers at femtomolar concentrations.

Diagnostic kit measures serum biomarkers to predict antidepressant treatment response and remission in depressed patients.

Assessing free citrulline concentrations detects cardiovascular disease risk independent of traditional inflammatory markers and improves prediction accuracy.

Microfiltration isolates circulating cancer-associated macrophage-like cells from blood, resolving inconsistent detection of rare tumor cells in solid tumors.

Joint detection of YKL-40 and MASP2 proteins improves hepatocarcinoma diagnosis accuracy over traditional AFP methods.

Combined boosted flow cytometry and toggle peptides detect Th1 and Th2 cytokines, resolving limited sensitivity in traditional HIV-specific T cell assays.

A multiplexed nano-biosensor system uses electrochemical immunosensors to detect multiple diabetes biomarkers simultaneously.

SIFT-MS analyzes breath trimethylamine levels to diagnose alcoholic hepatitis without invasive liver biopsy risks.

HLA-DR+CD4+ T cell biomarkers assess daclizumab efficacy to address insufficient IFN-beta responses and anti-interferon antibody risks.

Specific anti-SOD1 antibodies enable high sensitivity detection of misfolded SOD1 in cerebrospinal fluid, resolving low concentration measurement challenges.

Combines neopterin with cardiovascular markers to detect bacterial infections in dyspneic patients.

Quantitative image analysis measures perivascular immune cell density to predict immunotherapy response and determine tumor prognosis.

Detecting phosphorylated RelB protein at serine residue 472 classifies solid cancer prognosis, addressing the lack of effective markers for metastasis risk.

Reporter oligonucleotide conjugated antigens isolate and identify antigen binding molecules.

A diagnostic test system detects pregnanediol glucuronide in urine using optical signals for immediate results.

Automated fluorescence detection replaces subjective scoring to quantify HER2 levels, identifying high-risk patients for targeted brain metastasis therapy.

Antibodies enable point-of-care olanzapine monitoring via lateral flow assays, replacing complex laboratory equipment.

Segmented gamma and hexagonal tungsten oxide sensors detect trace nitric oxide and isoprene, resolving precision versus complexity trade-offs.

Measuring 10-35 kDa MMP-8 fragments improves diagnostic sensitivity and specificity for predicting tissue degradation.

Analyze morphology to isolate rare cells, then culture in optimized medium to extend viability for genetic testing.

Analyzing peptide biomarker levels enables accurate prediction of patient response to erythropoietic agents, reducing morbidity from poor responders.

Segmented assay measures tissue factor induction to distinguish acquired from inherited disorders, resolving precision versus complexity trade-offs.

Pro-Enkephalin biomarkers resolve vasoactive peptide correlation failures in females by detecting reduced levels to predict breast and lung cancer.

Determining sFlt-1 concentrations before week twelve replaces complex uterine artery Doppler measurements with accessible blood tests.

RBP4 and NT-proBNP biomarkers classify ischemic versus hemorrhagic stroke.

Dynamic BH3 profiling measures mitochondrial outer membrane permeabilization to identify optimal cancer treatments despite insufficient traditional biomarkers.

Immunofluorescence assay detects disease-specific antigens on circulating extracellular vesicles using labeled antibodies.

A sandwich immunoassay uses specific capture and detection antibodies to quantify human B-type natriuretic peptide.

Metabolic analysis predicts opioid responsiveness via dopaminergic profiling to prevent tolerance and addiction risks.

A compressible applicator uses scratching barbs to deposit allergens onto patient skin for simultaneous testing.

A urinary biomarker panel measures alpha-1 microglobulin, KIM-1, and YKL-40 levels to assess kidney tubule health status.

Quantitative mass spectrometry identifies marker proteins via differential phosphorylation patterns in stimulated thrombocytes.

A non-invasive diagnostic method detects colonic inflammation by measuring specific biomarkers in stool samples.

Dual inhibition of HSP90 and BRAF destabilizes resistance client proteins, overcoming tumor adaptation and restoring therapeutic efficacy.

A biomarker panel assesses cognitive function using peripheral blood mononuclear cell markers.

Specific lipid biomarkers detected via mass spectrometry enable precise discrimination between inflammatory bowel disease patients and healthy controls.

Multi-marker panels using SELDI-MS improve diagnostic accuracy and sensitivity for early detection.

An antibody array detects ovarian cancer using a panel of five specific biomarkers.

Segmenting anti-PLA2R1 antibody responses by epitope ratios resolves unclear cut-off values and improves treatment response prediction.

Mast cell activation tests diagnose immediate hypersensitivity reactions by detecting degranulation, avoiding anaphylaxis risks from graded challenges.

A diagnostic method detects G M1 ganglioside distribution patterns on sperm membranes to assess capacitation status.